Stevens Capital Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Stevens Capital Management’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-322,251	Closed	-$5.46M	–	1439
2014 Q4	$5.46M	Buy	+322,251	New	+$4.53M	0.18%	147
2014 Q2	–	Sell	-62,690	Closed	-$230K	–	1497
2014 Q1	$230K	Buy	+62,690	New	+$239K	0.01%	887

Stevens Capital Management's AVNR Position: Q1 2015 in Review

Stevens Capital Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 322,251 shares — an estimated $5.46M sold.

Stevens Capital Management first reported a position in AVNR in Q1 2014 and held it in 2 quarters. The position peaked at $5.46M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Stevens Capital Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Stevens Capital Management sold 322,251 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $5.46M.
Stevens Capital Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q1 2014 and held it in 2 quarters.
Stevens Capital Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $5.46M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Stevens Capital Management's 13F filing for Q1 2015, filed 7 May 2015.